Pei-Fang Su

2.7k citations
41 papers · 690 indexed · h-index 15
Topics
Renal cell carcinoma treatment (2 papers)Bayesian Methods and Mixture Models (2 papers)Maternal Mental Health During Pregnancy and Postpartum (2 papers)
Partner nations
TaiwanUnited StatesChina

In The Last Decade

Pei-Fang Su

41 papers receiving 682 citations

Peers

Pei-Fang Su
Comparison fields: 5 of 132
  • Molecular Biology 245
  • Hepatology 118
  • Epidemiology 116
  • Endocrinology, Diabetes and Metabolism 74
  • Cancer Research 58
Replace Anita Balakrishnan with:
Anita Balakrishnan United Kingdom
Lydia Coulter Kwee United States
Zhifan Xiong China
Kiran Sharma India
Müjdat Zeybel Türkiye
Kendal Jensen United States
Shuling Liu China
Arkadiusz Niklas Poland
Hee Young Kim South Korea
Tuyet Thi Nguyen South Korea
Pei-Fang Su relative to Anita Balakrishnan United Kingdom Anita Balakrishnan's profile →
Citations per field
00.5×2.9×
Anita Balakrishnan · 1×
Citations per year

Countries citing papers authored by Pei-Fang Su

Since Specialization
Citations

This map shows the geographic impact of Pei-Fang Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pei-Fang Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pei-Fang Su more than expected).

Fields of papers citing papers by Pei-Fang Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pei-Fang Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pei-Fang Su. The network helps show where Pei-Fang Su may publish in the future.

Co-authorship network of co-authors of Pei-Fang Su

This figure shows the co-authorship network connecting the top 25 collaborators of Pei-Fang Su. A scholar is included among the top collaborators of Pei-Fang Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pei-Fang Su. Pei-Fang Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 3
3 13
4 40
5 15
6 2
7 5
8 4
9 15
10 4
11 18
12 16
13 9
14 109
15 10
16 32
17 5
18 6
19 59
20 12

About Pei-Fang Su

Pei-Fang Su is a scholar working on Medical Laboratory Technology, Aging and Biological Psychiatry, having authored 41 papers that have together received 690 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (2 papers), Bayesian Methods and Mixture Models (2 papers) and Maternal Mental Health During Pregnancy and Postpartum (2 papers). The work is most often cited by research in Hepatology (118 citations), Aging (26 citations) and Endocrinology, Diabetes and Metabolism (74 citations). Pei-Fang Su has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Yu Shyr, Huang‐Tz Ou, Shihchen Kuo, Chung-I Li, Chien‐Hung Chen, Shao-Chieh Lin, Chao‐Hung Hung, Peng-Chan Lin, Tsung‐Hui Hu and Chung-Ta Lee. Their work appears in journals such as Nature, PLoS ONE and Diabetes Care.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026